Contrast Media/Contrast Agent Market by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI, and Ultrasound), Application (Radiology), End User (Hospitals), Indication (Cancer), Route of Administration (Oral), Region - Global Forecast to 2026

Table of Contents

1 INTRODUCTION 41

1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 41
1.3 MARKET SCOPE 42
・ FIGURE 1 CONTRAST MEDIA/CONTRAST AGENTS MARKET SEGMENTATION 42
1.3.1 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 43
1.5 STAKEHOLDERS 43
1.6 SUMMARY OF CHANGES 44

2 RESEARCH METHODOLOGY 45

2.1 RESEARCH DATA 45
・ FIGURE 2 RESEARCH DESIGN 45
2.2 SECONDARY DATA 46
2.2.1 SECONDARY SOURCES 47
2.3 PRIMARY DATA 48
・ FIGURE 3 PRIMARY SOURCES 48
2.3.1 KEY DATA FROM PRIMARY SOURCES 49
2.3.2 KEY INDUSTRY INSIGHTS 50
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 50
2.4 MARKET SIZE ESTIMATION 51
・ FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 51
2.4.1 GROWTH FORECAST 52
・ FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 52
・ FIGURE 7 TOP-DOWN APPROACH 53
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 54
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY 54
2.6 MARKET SHARE ANALYSIS 54
2.7 ASSUMPTIONS FOR THE STUDY 55
2.7.1 COVID-19 SPECIFIC ASSUMPTIONS 55
2.8 LIMITATIONS 56
2.9 RISK ASSESSMENT 56
2.10 GROWTH RATE ASSUMPTIONS 57
2.11 COVID-19 ECONOMIC ASSESSMENT 57
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 57
・ FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 57
・ FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 59

3 EXECUTIVE SUMMARY 60

・ FIGURE 11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 60
・ FIGURE 12 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2021 VS. 2026 (USD MILLION) 61
・ FIGURE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2021 VS. 2026 (USD MILLION) 62
・ FIGURE 14 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2021 VS. 2026 (USD MILLION) 63
・ FIGURE 15 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 64
・ FIGURE 16 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 65
・ FIGURE 17 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 66

4 PREMIUM INSIGHTS 67

4.1 CONTRAST MEDIA/CONTRAST AGENTS MARKET OVERVIEW 67
・ FIGURE 18 INCREASING INCIDENCE OF CHRONIC DISORDERS TO DRIVE MARKET GROWTH 67
4.2 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE (2021–2026) 68
・ FIGURE 19 MICROBUBBLE CONTRAST MEDIA SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 68
4.3 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE AND COUNTRY (2020) 69
・ FIGURE 20 THE US DOMINATED THE NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2020 69
4.4 CONTRAST MEDIA/CONTRAST AGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70
・ FIGURE 21 INDIA AND CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 70

5 MARKET OVERVIEW 71

5.1 INTRODUCTION 71
・ FIGURE 22 CONTRAST MEDIA/CONTRAST AGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.2 MARKET DYNAMICS 72
5.2.1 DRIVERS 72
5.2.1.1 RISING PREVALENCE OF CHRONIC DISEASES 72
・ TABLE 1 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 72
5.2.1.2 GROWING APPROVALS OF CONTRAST AGENTS 72
5.2.1.3 RISING VOLUME OF CT AND MRI EXAMINATIONS PERFORMED 73
・ TABLE 2 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2010 VS. 2018 74
・ TABLE 3 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2010 VS. 2018 74
5.2.1.4 GROWING NUMBER OF DIAGNOSTIC CENTERS AND HOSPITALS 74
5.2.1.5 AVAILABILITY OF REIMBURSEMENT 75
5.2.2 RESTRAINTS 75
5.2.2.1 SIDE-EFFECTS AND ALLERGIC REACTIONS ASSOCIATED WITH CONTRAST AGENTS 75
・ TABLE 4 LIST OF SIDE-EFFECTS/REACTIONS TO CONTRAST MEDIA 75
5.2.3 OPPORTUNITIES 76
5.2.3.1 GENERIC CONTRAST MEDIA 76
5.2.3.2 INCREASING RESEARCH ON CONTRAST AGENTS 77
・ TABLE 5 INDICATIVE LIST OF RESEARCH STUDIES 77
5.2.4 CHALLENGES 78
5.2.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING SOLUTIONS 78
5.2.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS 78
5.2.4.3 DEARTH OF TRAINED PROFESSIONALS 79
・ TABLE 6 METROPOLITAN AREAS IN THE US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS 79
5.3 RANGES/SCENARIOS 80
5.3.1 CONTRAST MEDIA/CONTRAST AGENTS MARKET FORECAST 80
・ FIGURE 23 PESSIMISTIC SCENARIO 80
・ FIGURE 24 OPTIMISTIC SCENARIO 80
・ FIGURE 25 REALISTIC SCENARIO 81
5.4 COVID-19 IMPACT ON THE CONTRAST MEDIA/CONTRAST AGENTS MARKET 81
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 83
5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR CONTRAST MEDIA/CONTRAST AGENT MANUFACTURERS 83
5.5.2 REVENUE SHIFT FOR CONTRAST MEDIA/CONTRAST AGENTS MARKET 83
5.6 PRICING ANALYSIS 84
・ TABLE 7 PRICES OF CONTRAST MEDIA/CONTRAST AGENTS 84
5.7 SUPPLY CHAIN ANALYSIS 84
・ FIGURE 26 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES 85
5.8 VALUE CHAIN ANALYSIS 85
・ FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE DEVELOPMENT PHASE 86
5.9 ECOSYSTEM ANALYSIS 86
5.9.1 ROLE IN THE ECOSYSTEM 87
・ TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM 87
・ FIGURE 28 KEY PLAYERS IN THE CONTRAST MEDIA/CONTRAST AGENTS ECOSYSTEM 88
5.10 TECHNOLOGY ANALYSIS 88
5.11 PATENT ANALYSIS 89
5.12 TRADE ANALYSIS 90
・ TABLE 9 IMPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS; DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2016-2020 (USD MILLION) 90
・ TABLE 10 EXPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS; DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2016-2020 (USD MILLION) 90
5.13 REGULATORY LANDSCAPE 90
・ TABLE 11 LIST OF REGULATORY AUTHORITIES IN THE PHARMACEUTICAL INDUSTRY 91
5.13.1 EU REGULATIONS 92
5.13.2 FDA REGULATIONS 92
5.13.3 JPMA REGULATIONS 93
5.14 PORTER’S FIVE FORCES ANALYSIS 93
・ TABLE 12 PORTER’S FIVE FORCES 93
5.14.1 INTENSITY OF COMPETITIVE RIVALRY 93
5.14.2 BARGAINING POWER OF SUPPLIERS 93
5.14.3 BARGAINING POWER OF BUYERS 93
5.14.4 THREAT OF SUBSTITUTES 93
5.14.5 THREAT OF NEW ENTRANTS 94

6 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE 95

6.1 INTRODUCTION 96
6.2 PRIMARY NOTES 96
・ TABLE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 96
・ TABLE 14 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 97
6.3 IODINATED CONTRAST MEDIA 97
6.3.1 CONSUMPTION OF IODINATED CONTRAST MEDIA IS HIGH DUE TO THE HIGHER DOSAGE REQUIRED IN CT SCANS—A KEY FACTOR DRIVING MARKET GROWTH 97
・ TABLE 15 IODINATED CONTRAST MEDIA MARKET, BY REGION,
2017–2019 (USD MILLION) 98
・ TABLE 16 IODINATED CONTRAST MEDIA MARKET, BY REGION,
2020–2026 (USD MILLION) 98
6.4 GADOLINIUM-BASED CONTRAST MEDIA 99
6.4.1 SUSPICION REGARDING THE SAFETY PROFILE OF GADOLINIUM-BASED CONTRAST AGENTS TO CHALLENGE MARKET GROWTH TO A CERTAIN EXTENT 99
・ TABLE 17 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION,
2017–2019 (USD MILLION) 100
・ TABLE 18 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION,
2020–2026 (USD MILLION) 100
6.5 MICROBUBBLE CONTRAST MEDIA 100
6.5.1 MICROBUBBLES ARE CONVENIENT, COMPLETELY RADIATION-FREE, AND VERSATILE, MAKING THEM EXTREMELY POPULAR WITH PHYSICIANS WORLDWIDE 100
・ TABLE 19 MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION,
2017–2019 (USD MILLION) 101
・ TABLE 20 MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION,
2020–2026 (USD MILLION) 101
6.6 BARIUM-BASED CONTRAST MEDIA 102
6.6.1 BARIUM-BASED CONTRAST MEDIA CAN CAUSE ADVERSE EFFECTS IN PATIENTS LIKE PERFORATION OF THE PERITONEUM—THIS IS EXPECTED TO NEGATIVELY IMPACT THE MARKET 102
・ TABLE 21 BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION,
2017–2019 (USD MILLION) 102
・ TABLE 22 BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION,
2020–2026 (USD MILLION) 103

7 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY 104

7.1 INTRODUCTION 105
7.2 PRIMARY NOTES 105
・ TABLE 23 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 105
・ TABLE 24 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 106
7.3 X-RAY/CT 106
7.3.1 X-RAY/CT SEGMENT ACCOUNTS FOR THE LARGEST SHARE OF THE CONTRAST MEDIA/CONTRAST AGENTS MARKET 106
・ TABLE 25 NUMBER OF X-RAY AND CT SCANS IN ENGLAND 107
・ TABLE 26 INSTALLED BASE OF CT SCANNERS, BY REGION, 2017 VS. 2018 107
・ TABLE 27 CT PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION) 107
・ TABLE 28 X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017–2019 (USD MILLION) 107
・ TABLE 29 X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 108
7.4 MAGNETIC RESONANCE IMAGING 108
7.4.1 GROWING NUMBER OF MRI SCANNERS AND INCREASING MRI EXAMINATIONS ARE DRIVING MARKET GROWTH 108
・ TABLE 30 INSTALLED BASE OF MRI SYSTEMS, BY REGION, 2017 VS. 2018 109
・ TABLE 31 MRI PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION) 109
・ TABLE 32 NUMBER OF MRI PROCEDURES IN ENGLAND 109
・ TABLE 33 MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2017–2019 (USD MILLION) 110
・ TABLE 34 MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 110
7.5 ULTRASOUND 110
7.5.1 ULTRASOUND SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 110
・ TABLE 35 NUMBER OF ULTRASOUND PROCEDURES IN ENGLAND 111
・ TABLE 36 ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017–2019 (USD MILLION) 112
・ TABLE 37 ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 112

8 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION 113

8.1 INTRODUCTION 114
・ TABLE 38 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 114
・ TABLE 39 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 114
8.2 INTRAVASCULAR ROUTE 115
8.2.1 WIDESPREAD USE OF INTRAVASCULAR ROUTES OF ADMINISTRATION IN IMAGING MODALITIES TO DRIVE MARKET GROWTH 115
8.2.1.1 INTRAVENOUS (IV) ROUTE 115
8.2.1.2 INTRA-ARTERIAL (IA) ROUTE 115
・ TABLE 40 INTRAVASCULAR CONTRAST MEDIA MARKET, BY REGION,
2017–2019 (USD MILLION) 116
・ TABLE 41 INTRAVASCULAR CONTRAST MEDIA MARKET, BY REGION,
2020–2026 (USD MILLION) 116
8.3 ORAL ROUTE 116
8.3.1 USE OF ORAL CONTRAST MEDIA CAN LEAD TO PERFORATIONS IN THE GIT, LEADING TO PERITONITIS—THIS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT 116
・ TABLE 42 ORAL CONTRAST MEDIA MARKET, BY REGION, 2017–2019 (USD MILLION) 117
・ TABLE 43 ORAL CONTRAST MEDIA MARKET, BY REGION, 2020–2026 (USD MILLION) 117
8.4 RECTAL ROUTE 118
8.4.1 MILD DISCOMFORT ASSOCIATED WITH RECTAL CONTRAST MEDIA TO LIMIT MARKET GROWTH 118
・ TABLE 44 RECTAL CONTRAST MEDIA MARKET, BY REGION, 2017–2019 (USD MILLION) 118
・ TABLE 45 RECTAL CONTRAST MEDIA MARKET, BY REGION, 2020–2026 (USD MILLION) 119
8.5 OTHER ROUTES OF ADMINISTRATION 119
・ TABLE 46 OTHER CONTRAST MEDIA MARKET, BY REGION, 2017–2019 (USD MILLION) 119
・ TABLE 47 OTHER CONTRAST MEDIA MARKET, BY REGION, 2020–2026 (USD MILLION) 120

9 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION 121

9.1 INTRODUCTION 122
9.2 PRIMARY NOTES 122
・ TABLE 48 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2017–2019 (USD MILLION) 122
・ TABLE 49 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2020–2026 (USD MILLION) 123
9.3 CARDIOVASCULAR DISORDERS 123
9.3.1 CARDIOVASCULAR DISORDERS SEGMENT TO DOMINATE THE CONTRAST MEDIA/CONTRAST AGENTS MARKET 123
・ TABLE 50 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2017–2019 (USD MILLION) 124
・ TABLE 51 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2020–2026 (USD MILLION) 124
9.4 CANCER 124
9.4.1 ASIA PACIFIC MARKET TO REGISTER RELATIVELY HIGHER GROWTH OWING TO THE HIGH CANCER PREVALENCE IN THE REGION 124
・ TABLE 52 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 125
・ TABLE 53 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2017–2019 (USD MILLION) 125
・ TABLE 54 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2020–2026 (USD MILLION) 126
9.5 GASTROINTESTINAL DISORDERS 126
9.5.1 RISING PREVALENCE OF GI DISORDERS TO SUPPORT MARKET GROWTH 126
・ TABLE 55 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2017–2019 (USD MILLION) 126
・ TABLE 56 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2020–2026 (USD MILLION) 127
9.6 MUSCULOSKELETAL DISORDERS 127
9.6.1 RISING INCIDENCE OF WORK-RELATED MUSCULOSKELETAL DISORDERS TO SUPPORT MARKET GROWTH 127
・ TABLE 57 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2017–2019 (USD MILLION) 128
・ TABLE 58 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2020–2026 (USD MILLION) 128
9.7 NEUROLOGICAL DISORDERS 128
9.7.1 RISING PREVALENCE OF DEMENTIA TO DRIVE MARKET GROWTH 128
・ TABLE 59 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2017–2019 (USD MILLION) 129
・ TABLE 60 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2020–2026 (USD MILLION) 129
9.8 NEPHROLOGICAL DISORDERS 130
9.8.1 RISING PREVALENCE OF ESRD IS DRIVING THE DEMAND FOR DIAGNOSTIC TOOLS FOR KIDNEY DISEASES 130
・ TABLE 61 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2017–2019 (USD MILLION) 130
・ TABLE 62 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2020–2026 (USD MILLION) 131

10 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION 132

10.1 INTRODUCTION 133
・ TABLE 63 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 133
・ TABLE 64 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 133
10.2 RADIOLOGY 134
10.2.1 GROWING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THE RADIOLOGY APPLICATIONS SEGMENT 134
・ TABLE 65 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR RADIOLOGY,
BY REGION, 2017–2019 (USD MILLION) 134
・ TABLE 66 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR RADIOLOGY,
BY REGION, 2020–2026 (USD MILLION) 135
10.3 INTERVENTIONAL RADIOLOGY 135
10.3.1 INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH 135
・ TABLE 67 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2017–2019 (USD MILLION) 136
・ TABLE 68 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2020–2026 (USD MILLION) 136
10.4 INTERVENTIONAL CARDIOLOGY 136
10.4.1 RISING INCIDENCE OF CARDIAC DISORDERS TO DRIVE THE DEMAND FOR INTERVENTIONAL CARDIOLOGY PROCEDURES 136
・ TABLE 69 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2017–2019 (USD MILLION) 137
・ TABLE 70 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2020–2026 (USD MILLION) 138

11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER 139

11.1 INTRODUCTION 140
・ TABLE 71 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 140
・ TABLE 72 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 140
11.2 HOSPITAL, CLINICS, AND AMBULATORY SURGERY CENTERS 140
11.2.1 INCREASING ADOPTION OF DIAGNOSTIC IMAGING MODALITIES ACROSS HOSPITALS TO DRIVE MARKET GROWTH 140
・ TABLE 73 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2017–2019 (USD MILLION) 141
・ TABLE 74 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2026 (USD MILLION) 142
11.3 DIAGNOSTIC IMAGING CENTERS 142
11.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET GROWTH IN THE COMING YEARS 142
・ TABLE 75 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2017–2019 (USD MILLION) 142
・ TABLE 76 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020–2026 (USD MILLION) 143

12 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION 144

12.1 INTRODUCTION 145
・ TABLE 77 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2017–2019 (USD MILLION) 145
・ TABLE 78 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 145
12.2 NORTH AMERICA 146
・ FIGURE 29 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET SNAPSHOT 146
・ TABLE 79 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY COUNTRY, 2017–2019 (USD MILLION) 147
・ TABLE 80 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY COUNTRY, 2020–2026 (USD MILLION) 147
・ TABLE 81 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 147
・ TABLE 82 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 148
・ TABLE 83 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY MODALITY, 2017–2019 (USD MILLION) 148
・ TABLE 84 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY MODALITY, 2020–2026 (USD MILLION) 148
・ TABLE 85 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 149
・ TABLE 86 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 149
・ TABLE 87 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY INDICATION, 2017–2019 (USD MILLION) 149
・ TABLE 88 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY INDICATION, 2020–2026 (USD MILLION) 150
・ TABLE 89 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2017–2019 (USD MILLION) 150
・ TABLE 90 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 150
・ TABLE 91 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY END USER, 2017–2019 (USD MILLION) 151
・ TABLE 92 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY END USER, 2020–2026 (USD MILLION) 151
12.2.1 US 151
12.2.1.1 THE US DOMINATES THE NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENTS MARKET 151
・ TABLE 93 US: KEY MACROINDICATORS 152
・ TABLE 94 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 152
・ TABLE 95 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 153
・ TABLE 96 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 153
・ TABLE 97 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 153
・ TABLE 98 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 154
・ TABLE 99 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 154
・ TABLE 100 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2017–2019 (USD MILLION) 154
・ TABLE 101 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2020–2026 (USD MILLION) 155
・ TABLE 102 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 155
・ TABLE 103 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 155
・ TABLE 104 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 156
・ TABLE 105 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 156
12.2.2 CANADA 156
12.2.2.1 INCREASING INVESTMENTS IN IMPROVING MEDICAL IMAGING—A MAJOR FACTOR DRIVING MARKET GROWTH IN CANADA 156
・ TABLE 106 CANADA: KEY MACROINDICATORS 157
・ TABLE 107 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 157
・ TABLE 108 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 158
・ TABLE 109 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 158
・ TABLE 110 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 158
・ TABLE 111 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 159
・ TABLE 112 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 159
・ TABLE 113 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 159
・ TABLE 114 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 160
・ TABLE 115 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 160
・ TABLE 116 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 160
・ TABLE 117 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 161
・ TABLE 118 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 161
12.3 EUROPE 161
・ TABLE 119 TOTAL NUMBER OF MRI UNITS PER 1,000,000 INHABITANTS, 2017 162
・ TABLE 120 TOTAL NUMBER OF MRI EXAMS PER 1,000 INHABITANTS, 2017 162
・ TABLE 121 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 162
・ TABLE 122 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 163
・ TABLE 123 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 163
・ TABLE 124 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 164
・ TABLE 125 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 164
・ TABLE 126 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 164
・ TABLE 127 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 165
・ TABLE 128 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 165
・ TABLE 129 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 165
・ TABLE 130 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 166
・ TABLE 131 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 166
・ TABLE 132 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 166
・ TABLE 133 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 167
・ TABLE 134 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 167
12.3.1 GERMANY 167
12.3.1.1 PRESENCE OF A WELL-DEVELOPED DIAGNOSTIC IMAGING INFRASTRUCTURE IS A MAJOR FACTOR SUPPORTING MARKET GROWTH IN GERMANY 167
・ TABLE 135 GERMANY: KEY MACROINDICATORS 168
・ TABLE 136 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 168
・ TABLE 137 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 169
・ TABLE 138 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 169
・ TABLE 139 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 169
・ TABLE 140 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 170
・ TABLE 141 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 170
・ TABLE 142 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 170
・ TABLE 143 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 171
・ TABLE 144 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2017–2019 (USD MILLION) 171
・ TABLE 145 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 171
・ TABLE 146 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 172
・ TABLE 147 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 172
12.3.2 UK 172
12.3.2.1 INCREASING INVESTMENTS IN THE FIELD OF DIAGNOSTIC IMAGING TO BOOST THE MARKET GROWTH 172
・ TABLE 148 UK: KEY MACROINDICATORS 173
・ TABLE 149 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 173
・ TABLE 150 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 174
・ TABLE 151 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 174
・ TABLE 152 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 174
・ TABLE 153 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 175
・ TABLE 154 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 175
・ TABLE 155 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2017–2019 (USD MILLION) 175
・ TABLE 156 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION,
2020–2026 (USD MILLION) 176
・ TABLE 157 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 176
・ TABLE 158 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 176
・ TABLE 159 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 177
・ TABLE 160 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 177
12.3.3 FRANCE 177
12.3.3.1 INCREASING PREVALENCE OF CANCER WILL DRIVE THE MARKET FOR CONTRAST MEDIA IN FRANCE 177
・ TABLE 161 FRANCE: KEY MACROINDICATORS 178
・ TABLE 162 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 178
・ TABLE 163 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 178
・ TABLE 164 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 179
・ TABLE 165 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 179
・ TABLE 166 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 179
・ TABLE 167 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 180
・ TABLE 168 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 180
・ TABLE 169 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 181
・ TABLE 170 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 181
・ TABLE 171 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 181
・ TABLE 172 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 182
・ TABLE 173 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 182
12.3.4 SPAIN 182
12.3.4.1 SHORTAGE OF RADIOLOGISTS IN THE COUNTRY TO RESTRAIN THE MARKET GROWTH 182
・ TABLE 174 SPAIN: KEY MACROINDICATORS 183
・ TABLE 175 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 183
・ TABLE 176 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 183
・ TABLE 177 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 184
・ TABLE 178 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 184
・ TABLE 179 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 184
・ TABLE 180 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 185
・ TABLE 181 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 185
・ TABLE 182 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 186
・ TABLE 183 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 186
・ TABLE 184 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 186
・ TABLE 185 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 187
・ TABLE 186 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 187
12.3.5 ITALY 187
12.3.5.1 RISING GERIATRIC POPULATION LIKELY TO DRIVE THE DEMAND FOR DIAGNOSTIC PROCEDURES IN ITALY 187
・ TABLE 187 ITALY: KEY MACROINDICATORS 188
・ TABLE 188 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 188
・ TABLE 189 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 188
・ TABLE 190 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 189
・ TABLE 191 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 189
・ TABLE 192 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 189
・ TABLE 193 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 190
・ TABLE 194 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 190
・ TABLE 195 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 191
・ TABLE 196 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 191
・ TABLE 197 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 191
・ TABLE 198 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 192
・ TABLE 199 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 192
12.3.6 REST OF EUROPE 192
・ TABLE 200 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 193
・ TABLE 201 ROE: NUMBER OF UNITS AND NUMBER OF SCANS, BY COUNTRY, 2018 193
・ TABLE 202 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 193
・ TABLE 203 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 194
・ TABLE 204 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 194
・ TABLE 205 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 194
・ TABLE 206 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 195
・ TABLE 207 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 195
・ TABLE 208 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 195
・ TABLE 209 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 196
・ TABLE 210 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 196
・ TABLE 211 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 196
・ TABLE 212 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 197
・ TABLE 213 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 197
12.4 ASIA PACIFIC 197
・ FIGURE 30 ASIA PACIFIC: CONTRAST MEDIA/CONTRAST AGENTS MARKET SNAPSHOT 198
・ TABLE 214 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 199
・ TABLE 215 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 199
・ TABLE 216 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 199
・ TABLE 217 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 200
・ TABLE 218 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 200
・ TABLE 219 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 200
・ TABLE 220 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 201
・ TABLE 221 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 201
・ TABLE 222 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 201
・ TABLE 223 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 202
・ TABLE 224 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 202
・ TABLE 225 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 202
・ TABLE 226 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 203
・ TABLE 227 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 203
12.4.1 JAPAN 203
12.4.1.1 JAPAN DOMINATES THE APAC CONTRAST MEDIA/CONTRAST AGENTS MARKET 203
・ TABLE 228 JAPAN: KEY MACROINDICATORS 204
・ TABLE 229 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 204
・ TABLE 230 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 205
・ TABLE 231 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 205
・ TABLE 232 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 205
・ TABLE 233 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 206
・ TABLE 234 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 206
・ TABLE 235 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 206
・ TABLE 236 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 207
・ TABLE 237 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 207
・ TABLE 238 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 207
・ TABLE 239 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 208
・ TABLE 240 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 208
12.4.2 CHINA 208
12.4.2.1 HIGH INCIDENCE OF CANCER AND STROKES WILL SUPPORT THE MARKET FOR CONTRAST MEDIA IN CHINA 208
・ TABLE 241 CHINA: KEY MACROINDICATORS 209
・ TABLE 242 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 209
・ TABLE 243 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 209
・ TABLE 244 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 210
・ TABLE 245 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 210
・ TABLE 246 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 210
・ TABLE 247 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 211
・ TABLE 248 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 211
・ TABLE 249 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 212
・ TABLE 250 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 212
・ TABLE 251 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 212
・ TABLE 252 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 213
・ TABLE 253 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 213
12.4.3 INDIA 213
12.4.3.1 GROWING INVESTMENTS IN THE INDIAN RADIOLOGY MARKET WILL PROPEL MARKET GROWTH 213
・ TABLE 254 INDIA: KEY MACROINDICATORS 214
・ TABLE 255 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 214
・ TABLE 256 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 215
・ TABLE 257 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 215
・ TABLE 258 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 215
・ TABLE 259 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 216
・ TABLE 260 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 216
・ TABLE 261 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 216
・ TABLE 262 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 217
・ TABLE 263 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 217
・ TABLE 264 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 217
・ TABLE 265 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 218
・ TABLE 266 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 218
12.4.4 REST OF ASIA PACIFIC 218
・ TABLE 267 NUMBER OF MRI AND CT UNITS PER MILLION POPULATION, PER COUNTRY, 2019 219
・ TABLE 268 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 219
・ TABLE 269 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 220
・ TABLE 270 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 220
・ TABLE 271 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 220
・ TABLE 272 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 221
・ TABLE 273 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 221
・ TABLE 274 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 221
・ TABLE 275 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 222
・ TABLE 276 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 222
・ TABLE 277 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 222
・ TABLE 278 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017–2019 (USD MILLION) 223
・ TABLE 279 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020–2026 (USD MILLION) 223
12.5 LATIN AMERICA 223
12.5.1 INCREASING HEALTHCARE ACCESS IS EXPECTED TO DRIVE MARKET GROWTH 223
・ TABLE 280 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 224
・ TABLE 281 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 224
・ TABLE 282 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY MODALITY, 2017–2019 (USD MILLION) 225
・ TABLE 283 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY MODALITY, 2020–2026 (USD MILLION) 225
・ TABLE 284 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 225
・ TABLE 285 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 226
・ TABLE 286 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY INDICATION, 2017–2019 (USD MILLION) 226
・ TABLE 287 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY INDICATION, 2020–2026 (USD MILLION) 227
・ TABLE 288 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2017–2019 (USD MILLION) 227
・ TABLE 289 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 227
・ TABLE 290 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY END USER, 2017–2019 (USD MILLION) 228
・ TABLE 291 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET,
BY END USER, 2020–2026 (USD MILLION) 228
12.6 MIDDLE EAST & AFRICA 228
12.6.1 POOR REIMBURSEMENT SYSTEMS EXPECTED TO RESTRAIN MARKET GROWTH 228
・ TABLE 292 ISRAEL: DIAGNOSTIC IMAGING DATA, 2019 229
・ TABLE 293 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 229
・ TABLE 294 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 230
・ TABLE 295 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 230
・ TABLE 296 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 230
・ TABLE 297 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION) 231
・ TABLE 298 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2026 (USD MILLION) 231
・ TABLE 299 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017–2019 (USD MILLION) 231
・ TABLE 300 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020–2026 (USD MILLION) 232
・ TABLE 301 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 232
・ TABLE 302 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 232
・ TABLE 303 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2017–2019 (USD MILLION) 233
・ TABLE 304 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER,
2020–2026 (USD MILLION) 233

13 COMPETITIVE LANDSCAPE 234

13.1 OVERVIEW 234
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 234
・ TABLE 305 OVERVIEW OF STRATEGIES ADOPTED BY KEY CONTRAST MEDIA/CONTRAST AGENTS MARKET PLAYERS 234
13.3 MARKET SHARE ANALYSIS 236
・ FIGURE 31 CONTRAST MEDIA/CONTRAST AGENTS MARKET SHARE ANALYSIS, 2020 237
・ TABLE 306 CONTRAST MEDIA/CONTRAST AGENTS MARKET: DEGREE
OF COMPETITION (2020) 237
13.4 COMPANY EVALUATION QUADRANT 238
13.4.1 STARS 238
13.4.2 EMERGING LEADERS 238
13.4.3 PERVASIVE PLAYERS 239
13.4.4 PARTICIPANTS 239
・ FIGURE 32 CONTRAST MEDIA/CONTRAST AGENTS MARKET: COMPANY EVALUATION QUADRANT, 2020 239
13.5 COMPANY EVALUATION QUADRANT: SME/START-UPS 240
13.5.1 PROGRESSIVE COMPANIES 240
13.5.2 STARTING BLOCKS 240
13.5.3 RESPONSIVE COMPANIES 240
13.5.4 DYNAMIC COMPANIES 240
・ FIGURE 33 CONTRAST MEDIA/CONTRAST AGENTS MARKET: COMPANY EVALUATION QUADRANT FOR SME & START-UPS, 2020 241
13.6 COMPETITIVE SCENARIO 242
・ FIGURE 34 MARKET EVALUATION MATRIX, 2018–2021 242
13.6.1 DEALS 242
・ TABLE 307 DEALS 242
13.6.2 PRODUCT LAUNCHES/APPROVALS 243
・ TABLE 308 PRODUCT LAUNCHES/APPROVALS 243
13.6.3 OTHER DEVELOPMENTS 244
・ TABLE 309 OTHER DEVELOPMENTS 244
13.7 COMPANY FOOTPRINT ANALYSIS 244
・ TABLE 310 COMPANY FOOTPRINT ANALYSIS 244
・ TABLE 311 COMPANY PRODUCT FOOTPRINT 245
・ TABLE 312 COMPANY MODALITY FOOTPRINT 246
・ TABLE 313 COMPANY GEOGRAPHICAL FOOTPRINT 247

14 COMPANY PROFILES 249

14.1 KEY PLAYERS 249
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
14.1.1 GE HEALTHCARE 249
・ TABLE 314 GE HEALTHCARE: BUSINESS OVERVIEW 249
・ FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 250
14.1.2 BRACCO IMAGING SPA 253
・ TABLE 315 BRACCO IMAGING SPA: BUSINESS OVERVIEW 253
14.1.3 BAYER AG 257
・ TABLE 316 BAYER AG: BUSINESS OVERVIEW 257
・ FIGURE 36 BAYER AG: COMPANY SNAPSHOT (2020) 258
14.1.4 GUERBET 260
・ TABLE 317 GUERBET: BUSINESS OVERVIEW 260
・ FIGURE 37 GUERBET: COMPANY SNAPSHOT (2020) 261
14.1.5 LANTHEUS MEDICAL IMAGING 264
・ TABLE 318 LANTHEUS MEDICAL IMAGING: BUSINESS OVERVIEW 264
・ FIGURE 38 LANTHEUS MEDICAL IMAGING: COMPANY SNAPSHOT (2020) 265
14.1.6 UNIJULES LIFE SCIENCES 267
・ TABLE 319 UNIJULES LIFE SCIENCES: BUSINESS OVERVIEW 267
14.1.7 J.B. CHEMICALS AND PHARMACEUTICALS 268
・ TABLE 320 J.B. CHEMICALS AND PHARMACEUTICALS: BUSINESS OVERVIEW 268
・ FIGURE 39 J.B. CHEMICALS AND PHARMACEUTICALS LTD: COMPANY SNAPSHOT (2020) 268
14.1.8 SANOCHEMIA PHARMAZEUTIKA 270
・ TABLE 321 SANOCHEMIA PHARMAZEUTIKA: BUSINESS OVERVIEW 270
14.1.9 TAEJOON PHARM 271
・ TABLE 322 TAEJOON PHARM: BUSINESS OVERVIEW 271
14.1.10 JODAS EXPOIM 272
・ TABLE 323 JODAS EXPOIM: BUSINESS OVERVIEW 272
14.1.11 NANO THERAPEUTICS 273
・ TABLE 324 NANO THERAPEUTICS: BUSINESS OVERVIEW 273
14.1.12 KIRAN X-RAY 274
・ TABLE 325 KIRAN X-RAY: BUSINESS OVERVIEW 274
14.1.13 IMAX DIAGNOSTIC IMAGING LIMITED 275
・ TABLE 326 IMAX DIAGNOSTIC IMAGING: BUSINESS OVERVIEW 275
14.1.14 YANGTZE RIVER PHARMACEUTICAL GROUP 276
・ TABLE 327 YZJ GROUP: BUSINESS OVERVIEW 276
14.1.15 LIVEALTH BIOPHARMA 277
・ TABLE 328 LIVEALTH BIOPHARMA: BUSINESS OVERVIEW 277
14.2 OTHER PLAYERS 279
14.2.1 TRIVITRON HEALTHCARE 279
14.2.2 NOVALEK PHARMACEUTICALS 280
14.2.3 UNISPIRE BIOPHARMA PRIVATE LIMITED 281
14.2.4 ARCO LIFESCIENCES 282
14.2.5 CONGRUENT PHARMACHEM PRIVATE LIMITED 283
14.2.6 STANEX DRUGS & CHEMICAL 284
14.2.7 BEIJING BEILU PHARMACEUTICAL 285
14.2.8 REGE IMAGING & CINE FILMS 287
14.2.9 K DIAM EXIM 288
14.2.10 ONKO ILAÇ SAN. VE TIC. A.Ş. 289
14.2.11 SUBHRA PHARMA 290
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

15 APPENDIX 291

当レポートのプレスリリースは発行されておりません。